CD274 and squamous cell carcinoma of penis: Although clinical outcome data in pSCC patients treated with CPIs are scarce, one report noted a dramatic clinical response to ipilimumab and nivolumab in a chemotherapy-refractory patient with high PD-L1, high TMB, MSI-high, and dMMR [3].